Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (306K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (60)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Vihinen, M.
Right arrow Articles by Smith, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vihinen, M.
Right arrow Articles by Smith, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 26, Issue 1 242-247, Copyright © 1998 by Oxford University Press


ARTICLES

BTKbase, mutation database for X-linked agammaglobulinemia (XLA)

M Vihinen, O Brandau, LJ Branden, SP Kwan, I Lappalainen, T Lester, JG Noordzij, HD Ochs, J Ollila, SM Pienaar, P Riikonen, BK Saha and CIE Smith
Department of Biosciences, Division of Biochemistry, PO Box 56, FIN- 00014 University of Helsinki, Finland. mauno.vihinen@helsinki.fi

X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the gene coding for Bruton's agammaglobulinemia tyrosine kinase (BTK). A database (BTKbase) of BTK mutations has been compiled and the recent update lists 463 mutation entries from 406 unrelated families showing 303 unique molecular events. In addition to mutations, the database also lists variants or polymorphisms. Each patient is given a unique patient identity number (PIN). Information is included regarding the phenotype including symptoms. Mutations in all the five domains of BTK have been noticed to cause the disease, the most common event being missense mutations. The mutations appear almost uniformly throughout the molecule and frequently affect CpG sites that code for arginine residues. The putative structural implications of all the missense mutations are given in the database. The improved version of the registry having a number of new features is available at http://www. helsinki.fi/science/signal/btkbase.html
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
S. Guo, M. I. Wahl, and O. N. Witte
Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families
Int. Immunol., January 1, 2006; 18(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G Verbruggen, S De Backer, D Deforce, P Demetter, C Cuvelier, E Veys, and D Elewaut
X linked agammaglobulinaemia and rheumatoid arthritis
Ann Rheum Dis, July 1, 2005; 64(7): 1075 - 1078.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. W. Yu, R. S. Tabuchi, R. M. Kato, A. Astrakhan, S. Humblet-Baron, K. Kipp, K. Chae, W. Ellmeier, O. N. Witte, and D. J. Rawlings
Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer
Blood, September 1, 2004; 104(5): 1281 - 1290.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Martin, D. Wolf-Eichbaum, G. Duinkerken, W. A. Scherbaum, H. Kolb, J. G. Noordzij, and B. O. Roep
Development of Type 1 Diabetes despite Severe Hereditary B-Cell Deficiency
N. Engl. J. Med., October 4, 2001; 345(14): 1036 - 1040.
[Full Text] [PDF]


Home page
J. Immunol.Home page
E.-K. Jo, H. Kanegane, S. Nonoyama, S. Tsukada, J.-H. Lee, K. Lim, M. Shong, C.-H. Song, H.-J. Kim, J.-K. Park, et al.
Characterization of Mutations, Including a Novel Regulatory Defect in the First Intron, in Bruton's Tyrosine Kinase Gene from Seven Korean X-Linked Agammaglobulinemia Families
J. Immunol., October 1, 2001; 167(7): 4038 - 4045.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. F. Webb, Y. Yamashita, N. Ayers, S. Evetts, Y. Paulin, M. E. Conley, and E. A. Smith
The Transcription Factor Bright Associates with Bruton's Tyrosine Kinase, the Defective Protein in Immunodeficiency Disease
J. Immunol., December 15, 2000; 165(12): 6956 - 6965.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. H. Buckley
Primary Immunodeficiency Diseases Due to Defects in Lymphocytes
N. Engl. J. Med., November 2, 2000; 343(18): 1313 - 1324.
[Full Text] [PDF]


Home page
BloodHome page
T. W. LeBien
Fates of human B-cell precursors
Blood, July 1, 2000; 96(1): 9 - 23.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. T. Mattsson, I. Lappalainen, C.-M. Backesjo, E. Brockmann, S. Lauren, M. Vihinen, and C. I. E. Smith
Six X-Linked Agammaglobulinemia-Causing Missense Mutations in the Src Homology 2 Domain of Bruton's Tyrosine Kinase: Phosphotyrosine-Binding and Circular Dichroism Analysis
J. Immunol., April 15, 2000; 164(8): 4170 - 4177.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. A. E. Stenberg, P. T. Riikonen, and M. Vihinen
KinMutBase, a database of human disease-causing protein kinase mutations
Nucleic Acids Res., January 1, 2000; 28(1): 369 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Mao, M. Zhou, and F. M. Uckun
Crystal Structure of Bruton's Tyrosine Kinase Domain Suggests a Novel Pathway for Activation and Provides Insights into the Molecular Basis of X-linked Agammaglobulinemia
J. Biol. Chem., October 26, 2001; 276(44): 41435 - 41443.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.